Description
World Market for Biopharmaceutical Drug Delivery Device Technology
The total market for biopharmaceutical drug delivery is very complex and shifting due to technological advancements. Though the market to date has been dominated by injectable administration, injections are not the first choice among patients and compliance is an ongoing issue. Further, as the majority of new entities in development are biologics requiring advanced drug delivery, manufacturers of devices have been busy developing new innovations that will meet the current needs of biopharmaceuticals already on the market and future biopharmaceuticals in development. World Market for Biopharmaceutical Drug Delivery Device Technology identifies new innovations and examines the market by technology, by application and by region:
Market by Technology
- Market Size and Growth for Needle-free Biopharmaceutical Drug Delivery Device Market, 2018-2023 ($millions)
- Market Size and Growth for Transdermal Biopharmaceutical Drug Delivery Device Market, 2018-2023 ($millions)
- Market Size and Growth for Implants, Pumps and Microfluidic Biopharmaceutical Drug Delivery Device Market, 2018-2023 ($millions)
- Market Size and Growth for Other Biopharmaceutical Drug Delivery Device Market, 2018-2023 ($millions)
- Drug Delivery Device Market by Region 2018 by Percent (North America, Europe, Asia Pacific, ROW) (%)
- Drug Delivery Device Market by Region 2023 by Percent (North America, Europe, Asia Pacific, ROW) (%)
Market by Application
-
- Drug Delivery Device Market by Application 2018 (Diabetes, Cancer, Autoimmune, Cardiovascular, Neurological)
Market by Region
- World Market Size and Growth for Biopharmaceutical Drug Delivery Device Market, 2018-2023 ($millions)
- Market Size and Growth for North America Biopharmaceutical Drug Delivery Device Market, 2018-2023 ($millions)
- Market Size and Growth for European Biopharmaceutical Drug Delivery Device Market, 2018-2023 ($millions)
- European Biopharmaceutical Drug Delivery Device Market by Country, 2018 (Germany, Italy, France, UK, Spain, Others)
- Market Size and Growth for Asia Pacific Biopharmaceutical Drug Delivery Device Market, 2018-2023 ($millions)
- Asia Pacific Biopharmaceutical Drug Delivery Device Market by Country 2018 (Japan, China, India, Korea, Australia, Others)
- Market Size and Growth for RoW Biopharmaceutical Drug Delivery Device Market, 2018-2023 ($millions)
- RoW Biopharmaceutical Drug Delivery Device Market by Country, 2018 (Saudi Arabia, Latin America, South America, Africa, Others)
The development of safe, efficient, cost-effective needle-free devices has long been a major goal of the drug delivery community. The technology continues to advance as needle-free company marketers are evolving, searching for a strategy that will achieve commercial success. Companies have invested in new device models that incorporate design enhancements and improved engineering. The report discusses selected needle-free Injector systems, touching on implants, pumps, microfluidic technology, and transdermal technology.
World Market for Biopharmaceutical Drug Delivery Device Technology examines biopharmaceutical drug delivery technologies currently in development. These include:
- Microsphere Technology
- Targeted Technology
- Intracellular Delivery Technology
- MicroChip Technology
- Protein-Coated Microcrystal Technology
- Needle-Free Delivery Development
- Bolus Injectors
- Large Volume Wearable Injectors
- Combination Products
- Arrayed Microinjectors
Many of the drug development companies have products in development that utilize their proprietary drug delivery systems.
The number of companies providing biopharmaceutical drug delivery platforms continues to proliferate. The biopharmaceutical drug delivery device industry is comprised of companies seeking to develop novel alternatives to existing delivery systems, enhancements to existing systems, commercially enabling delivery systems that provide viable alternatives for biotherapeutics that are not fully developed and marketed because there are limited practical means of administration. The report profiles a selection of companies active in the market, including the following:
- 3M Pharmaceuticals
- Adocia
- Alkermes, Inc
- Antares Pharma
- Ascendis Pharma A/S
- Becton Dickinson and Company (BD)
- Bespak
- Catalent Pharma Solutions
- Credence MedSystems
- D’Antonio Consultants International
- Enable Injections, Inc
- Halozyme Therapeutics, Inc.
- InnoCore Pharmaceuticals, Inc.
- Inovio Pharmaceuticals, Inc.
- Insulet Corporation
- Intarcia Therapeutics, Inc.
- Ligand Pharmaceuticals, Inc.
- Medical International Technologies
- Medtronic, Inc.
- Micron Biomedical
- Mystic Pharmaceuticals
- Nektar Therapeutics
- Pharmajet, Inc.
- Portal Instruments, Inc.
- SHL Group
- Valeritas, Inc.
- West Pharmaceutical Services, Inc.
- Ypsomed AG
